1. Aeterna Zentaris Gmbh (7 from 36 patents)

2. Medigene Ag (3 from 48 patents)

3. Centre National De La Recherche Scientifique (1 from 5,104 patents)

4. University of Montpellier I (1 from 4 patents)

5. University of Montpellier Ii (1 from 4 patents)

6. Medigene Oncology Gmbh (1 from 2 patents)

7. Æterna Zentaris Gmbh (1 from 2 patents)

8. Syncore Biotechnology Co., Ltd. (3 patents)

1. 11644474 - Use of macimorelin in assessing growth hormone deficiency in children

2. 9238021 - Method of producing a cationic liposomal preparation comprising a lipophilic compound

3. 8912189 - Pyridopyrazine derivatives and their use

4. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors

5. 8663606 - Method of producing a cationic liposomal preparation comprising a lipophilic compound

6. 8546435 - Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors

7. 8541462 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors

8. 8470776 - Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

9. 8148546 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors

10. 8075913 - Method of producing a cationic liposomal preparation comprising a lipophilic compound

11. 7794747 - Method of producing a cationic liposomal preparation comprising a lipophilic compound

12. 7741277 - Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof